- Home
- OVID vs PYXS Comparison
OVID vs PYXS Comparison
Compare OVID & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- PYXS
- Stock Information
- Founded
- OVID 2014
- PYXS 2018
- Country
- OVID United States
- PYXS United States
- Employees
- OVID N/A
- PYXS N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- PYXS Health Care
- Exchange
- OVID Nasdaq
- PYXS Nasdaq
- Market Cap
- OVID 88.9M
- PYXS 79.4M
- IPO Year
- OVID 2017
- PYXS 2021
- Fundamental
- Price
- OVID $1.72
- PYXS $2.58
- Analyst Decision
- OVID Strong Buy
- PYXS Strong Buy
- Analyst Count
- OVID 4
- PYXS 5
- Target Price
- OVID $3.13
- PYXS $7.75
- AVG Volume (30 Days)
- OVID 5.1M
- PYXS 690.5K
- Earning Date
- OVID 11-11-2025
- PYXS 11-11-2025
- Dividend Yield
- OVID N/A
- PYXS N/A
- EPS Growth
- OVID N/A
- PYXS N/A
- EPS
- OVID N/A
- PYXS N/A
- Revenue
- OVID $6,651,000.00
- PYXS $2,820,000.00
- Revenue This Year
- OVID $1,086.57
- PYXS N/A
- Revenue Next Year
- OVID N/A
- PYXS N/A
- P/E Ratio
- OVID N/A
- PYXS N/A
- Revenue Growth
- OVID 1070.95
- PYXS N/A
- 52 Week Low
- OVID $0.24
- PYXS $0.83
- 52 Week High
- OVID $2.01
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- OVID 63.50
- PYXS 73.75
- Support Level
- OVID $1.24
- PYXS $2.10
- Resistance Level
- OVID $2.01
- PYXS $2.35
- Average True Range (ATR)
- OVID 0.20
- PYXS 0.18
- MACD
- OVID 0.03
- PYXS 0.02
- Stochastic Oscillator
- OVID 66.29
- PYXS 77.33
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.